Viome

Viome has acquired Sōlaria Biō in a move the company says will push its personalized nutrition business beyond gut microbiome testing. The deal signals Viome's ambition to build a broader health and nutrition platform, integrating new capabilities into its existing suite of at-home tests and tailored food and supplement recommendations. Industry observers see it as part of a wider trend of consolidation in the personalized health sector.

Health technology company Viome has acquired Sōlaria Biō, announcing plans to launch clinically validated consumer synbiotics and medical foods. The deal combines Viome's microbiome testing platform with Sōlaria Biō's formulation science, aiming to bring food-based therapeutic products to consumers backed by clinical evidence.